Hormonal Therapies in Cancers

Area of Science:

• Oncology
• Endocrinology

Background:

• Hormonal therapy is a well-established cancer treatment, particularly for breast cancer.
• Hormones like antiestrogens, aromatase restrictors, and luteinizing hormone-releasing hormone agonists have demonstrated efficacy.
• Hormonal therapy is also extensively used for managing menopause symptoms worldwide.

Purpose of the Study:

• To review the established role of hormonal therapy in cancer treatment.
• To examine the risks and benefits of hormonal therapy for menopause symptoms.
• To investigate the association between hormonal therapy and gynecological and colorectal cancers.

Main Methods:

• Literature review of hormonal therapies in cancer and menopause treatment.
• Analysis of studies on the impact of hormonal therapy on ovarian cancer risk.
• Examination of the relationship between postmenopausal hormone use and colorectal adenomas.

Main Results:

• Hormonal agents like antiestrogens and aromatase restrictors are effective in cancer treatment.
• Premenopausal and postmenopausal hormonal therapies are associated with an increased risk of ovarian cancer.
• The duration of hormonal therapy did not correlate with increased ovarian cancer risk.
• Postmenopausal hormone use showed an inverse relationship with major colorectal adenomas.

Conclusions:

• Hormonal therapy remains a cornerstone in cancer treatment and menopause management.
• While effective, hormonal therapy requires careful consideration of potential risks, such as ovarian cancer.
• Further research may clarify the complex relationship between hormonal therapy and various health outcomes.